Related Experiment Videos
Contaminated medication nebulizers in mechanical ventilator circuits. Source of bacterial aerosols
Abstract:
The contamination rates of medication nebulizers inserted into mechanical ventilator circuits were studied. Semiquantitative techniques were used to sample the reservoir fluid from in-line nebulizers during the first 24 hours after a circuit change. In the initial survey, high levels of contamination (organism concentrations above 10(3)/ml) were present in 13 (68 percent) of the 19 nebulizer reservoirs, and bacterial aerosols were produced by 10 (71 percent) of 14 nebulizers. Gram-negative bacilli were the predominant organisms isolated. Nebulizer contamination originated primarily from reflux of contaminated condensate in the ventilator circuit. When nebulizers were cleaned after each treatment, a reduced rate of contamination was found. Small bacterial aerosols (less than 3 microns in size) were produced in vitro after inoculation of nebulizers with gram-negative bacilli in concentrations isolated from in-use nebulizers. Contaminated in-line medication nebulizers generate small-particle bacterial aerosols that may increase the risk of ventilator-associated pneumonia and therefore should be cleaned or disinfected after each treatment rather than every 24 hours.
Insights
Contaminated medication nebulizers in mechanical ventilators can produce bacterial aerosols, increasing pneumonia risk. Cleaning nebulizers after each use, not every 24 hours, significantly reduces contamination.
Area of Science:
- Microbiology
- Infectious Disease Prevention
- Respiratory Care
Background:
- Mechanical ventilators are crucial for respiratory support but can harbor microbial contamination.
- Medication nebulizers, used to deliver drugs via ventilators, are potential sources of contamination and aerosol generation.
Purpose of the Study:
- To investigate the contamination rates of in-line medication nebulizers in mechanical ventilator circuits.
- To determine the source of nebulizer contamination and the potential for aerosolized bacteria generation.
- To evaluate the effectiveness of cleaning protocols on nebulizer contamination levels.
Main Methods:
- Semiquantitative sampling of reservoir fluid from in-line nebulizers within 24 hours of circuit changes.
- Identification of predominant organisms, including Gram-negative bacilli.
- In vitro studies to assess bacterial aerosol production from inoculated nebulizers.
Main Results:
- High contamination levels (>10(3)/ml) found in 68% of nebulizer reservoirs initially.
- Bacterial aerosols were produced by 71% of tested nebulizers.
- Contamination primarily stemmed from contaminated condensate reflux within the ventilator circuit.
- Cleaning nebulizers after each treatment significantly reduced contamination rates.
- Small bacterial aerosols (<3 microns) were generated in vitro.
Conclusions:
- Contaminated in-line medication nebulizers are a source of small-particle bacterial aerosols.
- These aerosols may elevate the risk of ventilator-associated pneumonia.
- Nebulizers should be cleaned or disinfected after each treatment, not on a 24-hour interval, to mitigate infection risk.